515 results on '"Mukoyama M"'
Search Results
2. WCN23-0810 THE EFFECTS OF SGLT2 INHIBITORS ON RENAL FUNCTION AND SERUM SODIUM CONCENTRATION TRENDES IN PATIENTS WITH TYPE 2 DIABETES
3. Vaccine targeting ANGPTL3 ameliorates dyslipidemia and associated diseases in mouse models of obese dyslipidemia and familial hypercholesterolemia
4. POS-328 SUPPRESSION OF ER-ASSOCIATED DEGRADATION BY INTRAGLOMERULAR CROSS-COMMUNICATION BETWEEN MESANGIAL CELLS AND PODOCYTES CAUSES PODOCYTE INJURY IN DIABETIC KIDNEY DISEASE
5. POS-018 A NOVEL ATP-RETAINING COMPOUND, KUS121, ENHANCES ER-ASSOCIATED DEGRADATION AND EXERTS RENOPROTECTIVE EFFECTS AGAINST ACUTE KIDNEY INJURY
6. Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice
7. POS-356 Suppression of ER-associated degradation by intraglomerular crosstalk between mesangial cells and podocytes causes podocyte injury in diabetic kidney disease
8. Transgenic overexpression of brain natriuretic peptide prevents the progression of diabetic nephropathy in mice
9. Roles of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: the effect of aspirin treatment
10. SUN-004 Osteocrin, a bone-originated humoral factor, exerts a renoprotective role in ischemia-reperfusion injury in mice
11. SUN-181 HIGH SERUM CALPROTECTIN LEVELS MAY PREDICT MORTALITY RISK IN HEMODIALYSIS PATIENTS WITH HIGH-PHOSPHATE CONDITIONS
12. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors
13. Immunocytochemical and ultrastructural studies of neuronal and oligodendroglial cytoplasmic inclusions in multiple system atrophy: 1. Neuronal cytoplasmic inclusions
14. Axonal degeneration of ascending sensory neurons in gracile axonal dystrophy mutant mouse
15. SUN-143 MATRIX METALLOPROTEINASE-10 (MMP-10) IS A KEY MOLECULE IN ALDOSTERONE-INDUCED GLOMERULAR INJURY IN SYSTEMIC GUANYLYL CYCLASE-A KNOCKOUT MICE
16. SAT-106 POTENTIAL ROLE OF MRP8 IN GLOMERULAR INJURY THROUGH INTRAGLOMERULAR CROSSTALK AFFECTING MACROPHAGE CHARACTERIZATION
17. SUN-297 INTRAGLOMERULAR CROSSTALK BETWEEN MESANGIAL CELLS AND PODOCYTES INHIBITS NORMAL ER-ASSOCIATED DEGRADATION PROCESSES AND INDUCES PODOCYTE INJURY IN DIABETIC KIDNEY DISEASE
18. Role of Leu-morphin, an Opioid Peptide, in the Central Regulation of Fluid Balance and Blood Pressure in Rats
19. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes with acanthocytosis: a clinicopathological study of a unique case
20. Neoplastic angioendotheliosis of the central nervous system
21. Neuropathology of gracile axonal dystrophy (GAD) mouse: An animal model of central distal axonopathy in primary sensory neurons
22. Japanese-western consensus meeting on biomarkers executive summary
23. Systemic thermal stimulation ameliorates renal tubular injury in a mouse model of renal ablation
24. Immunohistochemical localization of atrial natriuretic polypeptide (ANP) in human atrial and ventricular myocardiocytes
25. Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mice
26. Magnesium concentration in brains from multiple sclerosis patients
27. Adrenomedullin inhibits connective tissue growth factor expression, extracellular signal-regulated kinase activation and renal fibrosis
28. Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice
29. Temperature distribution measurement based on ML-EM using square type ultrasonic CT system.
30. BRAIN NATRIURETIC PEPTIDE ACTS LOCALLY AS AN ANTI-FIBROTIC FACTOR
31. Two brothers with frontotemporal dementia and parkinsonism with an N279K mutation of the tau gene
32. Involvement of the spinal posterior horn in Gerstmann-Straussler-Scheinker disease (PrP P102L)
33. Type 2 angiotensin II receptor is expressed in human myometrium and uterine leiomyoma and is down-regulated during pregnancy.
34. Umbilical venous guanosine 3',5'-cyclic phosphate (cGMP) concentration increases in asphyxiated newborns
35. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
36. Plasma concentration of atrial natriuretic peptide and brain natriuretic peptide during normal human pregnancy and the postpartum period
37. Angiotensin-Converting Enzyme and Genetic Hypertension: Cloning of Rat cDNAs and Characterization of the Enzyme
38. Cloning of cDNA and Analysis of the Gene for Mouse Angiotensin II Type 2 Receptor
39. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors.
40. Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy.
41. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction.
42. Low doses of endothelin-1 inhibit atrial natriuretic peptide secretion.
43. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.
44. Brain natriuretic peptide is present in the human amniotic fluid and is secreted from amnion cells.
45. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.
46. Phenotype-related alteration in expression of natriuretic peptide receptors in aortic smooth muscle cells.
47. Characterization of natriuretic peptide receptors in cultured cells.
48. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide.
49. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure.
50. Atrial natriuretic peptide in acute hypoxia-induced pulmonary hypertension in rats
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.